<!DOCTYPE html><html><head><title> Pacifica Code Section 26-55-S106 </title><link rel="stylesheet" href="/assets/style.css"/></head><body>
<b><i>
                      Effective 5/9/2017</i></b>
<br>
<b>26-55-106.&nbsp;
          </b><b>Overdose outreach providers.</b>
<br>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Notwithstanding Sections <a href="../../Title58/Chapter1/58-1-S501.html?v=C58-1-S501_2014040320140513">58-1-501</a>, <a href="../../Title58/Chapter17B/58-17b-S501.html?v=C58-17b-S501_2017050920170509">58-17b-501</a>, and <a href="../../Title58/Chapter17B/58-17b-S502.html?v=C58-17b-S502_2016051020160510">58-17b-502</a>:<a id="26-55-106(1)" name="26-55-106(1)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(1)</td><td style="width:99%">
an overdose outreach provider may:
<a id="26-55-106(1)(a)" name="26-55-106(1)(a)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(a)</td><td style="width:99%">
obtain an opiate antagonist dispensed on prescription by:<a id="26-55-106(1)(a)(i)" name="26-55-106(1)(a)(i)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(i)</td><td style="width:99%">
a health care provider, in accordance with Subsections <a href="../../Title26/Chapter55/26-55-S104.html?v=C26-55-S104_2017050920170509#26-55-104(2)">26-55-104(2)</a> and <a href="../../Title26/Chapter55/26-55-S104.html?v=C26-55-S104_2017050920170509#26-55-104(3)">(3)</a>; or</td>
</tr>
</tbody></table>
<a id="26-55-106(1)(a)(ii)" name="26-55-106(1)(a)(ii)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(ii)</td><td style="width:99%">
a pharmacist or pharmacy intern, as otherwise authorized by <a href="../../Title58/Chapter17B/58-17b.html?v=C58-17b_1800010118000101">Title 58, Chapter 17b, Pharmacy Practice Act</a>;</td>
</tr>
</tbody></table>
</td>
</tr>
</tbody></table>
<a id="26-55-106(1)(b)" name="26-55-106(1)(b)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(b)</td><td style="width:99%">
store the opiate antagonist; and</td>
</tr>
</tbody></table>
<a id="26-55-106(1)(c)" name="26-55-106(1)(c)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(c)</td><td style="width:99%">
furnish the opiate antagonist:<a id="26-55-106(1)(c)(i)" name="26-55-106(1)(c)(i)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(i)</td><td style="width:99%"><a id="26-55-106(1)(c)(i)(A)" name="26-55-106(1)(c)(i)(A)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(A)</td><td style="width:99%">
to an individual who is at increased risk of experiencing an opiate-related drug overdose event; or</td>
</tr>
</tbody></table>
<a id="26-55-106(1)(c)(i)(B)" name="26-55-106(1)(c)(i)(B)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(B)</td><td style="width:99%">
to a family member, friend, overdose outreach provider, or other individual who is in a position to assist an individual who is at increased risk of experiencing an opiate-related drug overdose event; and</td>
</tr>
</tbody></table>
</td>
</tr>
</tbody></table>
<a id="26-55-106(1)(c)(ii)" name="26-55-106(1)(c)(ii)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(ii)</td><td style="width:99%">
without liability for any civil damages for acts or omissions made as a result of furnishing the opiate antagonist in good faith; and</td>
</tr>
</tbody></table>
</td>
</tr>
</tbody></table>
</td>
</tr>
</tbody></table>
<a id="26-55-106(2)" name="26-55-106(2)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(2)</td><td style="width:99%">
when furnishing an opiate antagonist under Subsection <a href="#26-55-106(1)">(1)</a>, an overdose outreach provider:
<a id="26-55-106(2)(a)" name="26-55-106(2)(a)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(a)</td><td style="width:99%">
shall also furnish to the recipient of the opiate antagonist:<a id="26-55-106(2)(a)(i)" name="26-55-106(2)(a)(i)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(i)</td><td style="width:99%">
the written instruction under Subsection <a href="../../Title26/Chapter55/26-55-S104.html?v=C26-55-S104_2017050920170509#26-55-104(3)">26-55-104(3)</a> received by the overdose outreach provider from the health care provider at the time the opiate antagonist was dispensed to the overdose outreach provider; or</td>
</tr>
</tbody></table>
<a id="26-55-106(2)(a)(ii)" name="26-55-106(2)(a)(ii)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(ii)</td><td style="width:99%">
if the opiate antagonist was dispensed to the overdose outreach provider by a pharmacist or pharmacy intern, any written patient counseling under Section <a href="../../Title58/Chapter17B/58-17b-S613.html?v=C58-17b-S613_2015051220150512">58-17b-613</a> received by the overdose outreach provider at the time of dispensing; and</td>
</tr>
</tbody></table>
</td>
</tr>
</tbody></table>
<a id="26-55-106(2)(b)" name="26-55-106(2)(b)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(b)</td><td style="width:99%">
may provide additional instruction on how to recognize and respond appropriately to an opiate-related drug overdose event.</td>
</tr>
</tbody></table>
</td>
</tr>
</tbody></table>
<br>
<br>Amended by Chapter <a href="http://le.utah.gov/UtahCode/ChapterLookup.jsp?chap=392&amp;sess=2017GS">392</a>, 2017 General Session<br>
</body></html>